WEGOVY is not recommended in patients with severe gastroparesis. The label does not mention that Wegovy could cause gastroparesis, a claim in many Wegovy lawsuits
But the medicines list price is currently above $17,000 and, even when accounting for rebates paid by drug makers to health plans, the average annual cost is still higher (about $13,000) than its expected value
Peptides like GLP-1 receptor agonists (semaglutide, tirzepatide) and growth hormone secretagogues (CJC-1295, Ipamorelin) show significant potential in fat loss therapy
Learn why top health experts call it the "longevity molecule." Read more: Ever wonder if your GLP-1 medication is still safe after shipping in summer heat
Slow wave sleep disruption increases cerebrospinal fluid amyloid- levels
Claims data reflect routine clinical practice rather than mandatory assessments at prespecified time points, which may have impacted the amount of data available for observation